These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 12614326)
1. Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. Li Q; Wichems CH; Ma L; Van de Kar LD; Garcia F; Murphy DL J Neurochem; 2003 Mar; 84(6):1256-65. PubMed ID: 12614326 [TBL] [Abstract][Full Text] [Related]
2. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. Li Q; Wichems C; Heils A; Lesch KP; Murphy DL J Neurosci; 2000 Nov; 20(21):7888-95. PubMed ID: 11050108 [TBL] [Abstract][Full Text] [Related]
3. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817 [TBL] [Abstract][Full Text] [Related]
4. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat. Owens MJ; Ballenger CA; Knight DL; Nemeroff CB J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484 [TBL] [Abstract][Full Text] [Related]
6. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Rioux A; Fabre V; Lesch KP; Moessner R; Murphy DL; Lanfumey L; Hamon M; Martres MP Neurosci Lett; 1999 Mar; 262(2):113-6. PubMed ID: 10203244 [TBL] [Abstract][Full Text] [Related]
7. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain. Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964 [TBL] [Abstract][Full Text] [Related]
8. 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Huang XF; Huang X; Han M; Chen F; Storlien L; Lawrence AJ Brain Res; 2004 Aug; 1018(2):227-35. PubMed ID: 15276882 [TBL] [Abstract][Full Text] [Related]
9. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. Ase AR; Reader TA; Hen R; Riad M; Descarries L J Neurochem; 2001 Aug; 78(3):619-30. PubMed ID: 11483665 [TBL] [Abstract][Full Text] [Related]
10. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus. Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328 [TBL] [Abstract][Full Text] [Related]
11. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Misane I; Ogren SO Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830 [TBL] [Abstract][Full Text] [Related]
12. Functional study of rat 5-HT2A receptors using antisense oligonucleotides. Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE J Neurochem; 2003 Jun; 85(5):1087-100. PubMed ID: 12753068 [TBL] [Abstract][Full Text] [Related]
13. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Smith RL; Canton H; Barrett RJ; Sanders-Bush E Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567 [TBL] [Abstract][Full Text] [Related]
14. Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation. Pälvimäki EP; Majasuo H; Kuoppamäki M; Männistö PT; Syvälahti E; Hietala J Psychopharmacology (Berl); 1998 Mar; 136(2):99-104. PubMed ID: 9551765 [TBL] [Abstract][Full Text] [Related]
15. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. Zhang Y; Damjanoska KJ; Carrasco GA; Dudas B; D'Souza DN; Tetzlaff J; Garcia F; Hanley NR; Scripathirathan K; Petersen BR; Gray TS; Battaglia G; Muma NA; Van de Kar LD J Neurosci; 2002 Nov; 22(21):9635-42. PubMed ID: 12417689 [TBL] [Abstract][Full Text] [Related]
16. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies]. Adrien J J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953 [TBL] [Abstract][Full Text] [Related]
17. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bliziotes MM; Eshleman AJ; Zhang XW; Wiren KM Bone; 2001 Nov; 29(5):477-86. PubMed ID: 11704501 [TBL] [Abstract][Full Text] [Related]
18. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence. Martin CB; Martin VS; Trigo JM; Chevarin C; Maldonado R; Fink LH; Cunningham KA; Hamon M; Lanfumey L; Mongeau R Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522398 [TBL] [Abstract][Full Text] [Related]
19. Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein. Shi J; Damjanoska KJ; Zemaitaitis B; Garcia F; Carrasco G; Sullivan NR; She Y; Young KH; Battaglia G; Van De kar LD; Howland DS; Muma NA Neuropharmacology; 2006 Sep; 51(3):524-35. PubMed ID: 16769091 [TBL] [Abstract][Full Text] [Related]
20. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Bagdy G Behav Brain Res; 1996; 73(1-2):277-80. PubMed ID: 8788518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]